LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Effect of β-blockers on mortality in patients with sepsis: A propensity-score matched analysis.

Ge, Cheng-Long / Zhang, Li-Na / Ai, Yu-Hang / Chen, Wei / Ye, Zhi-Wen / Zou, Yu / Peng, Qian-Yi

Frontiers in cellular and infection microbiology

2023  Volume 13, Page(s) 1121444

Abstract: Objectives: We aimed to evaluate the association between β-blocker therapy and mortality in patients with sepsis.: Methods: Patients with sepsis were selected from the Medical Information Mart for Intensive Care (MIMIC)-III. Propensity score matching ...

Abstract Objectives: We aimed to evaluate the association between β-blocker therapy and mortality in patients with sepsis.
Methods: Patients with sepsis were selected from the Medical Information Mart for Intensive Care (MIMIC)-III. Propensity score matching (PSM) was used to balance the baseline differences. A multivariate Cox regression model was used to assess the relationship between β-blocker therapy and mortality. The primary outcome was the 28-day mortality.
Results: A total of 12,360 patients were included in the study, involving 3,895 who received β-blocker therapy and 8,465 who did not. After PSM, 3,891 pairs of patients were matched. The results showed that β-blockers were associated with improved 28- (hazards ratio (HR) 0.78) and 90-day (HR 0.84) mortality. Long-acting β-blockers were associated with improved 28-day survival (757/3627 [20.9%] vs. 583/3627 [16.1%],
Conclusions: β-blockers were associated with improved 28- and 90-day mortality in patients with sepsis and septic shock. Long-acting β-blocker therapy may have a protective role in patients with sepsis, reducing the 28-day and 90-day mortality. However, short-acting β-blocker (esmolol) treatment did not reduce the mortality in sepsis.
MeSH term(s) Humans ; Propensity Score ; Sepsis/drug therapy ; Adrenergic beta-Antagonists/therapeutic use ; Shock, Septic/drug therapy ; Retrospective Studies
Chemical Substances Adrenergic beta-Antagonists
Language English
Publishing date 2023-03-28
Publishing country Switzerland
Document type Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID 2619676-1
ISSN 2235-2988 ; 2235-2988
ISSN (online) 2235-2988
ISSN 2235-2988
DOI 10.3389/fcimb.2023.1121444
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top